Genetic variation in the tau protein phosphatase-2A pathway is not associated with Alzheimer's disease risk

Ver/Abrir
Identificadores
URI: http://hdl.handle.net/10902/1800
ISSN: 1756-0500
Compartir
Estadísticas
Ver Estadísticas
Google Scholar
Registro completo
Mostrar el registro completo DC
Autoría
Vázquez Higuera, José Luis; Mateo Fernández, José Ignacio; Sánchez-Juan, PascualAutoridad Unican; Rodríguez Rodríguez, Eloy ManuelAutoridad Unican; Pozueta, Ana; Calero Lara, Miguel; Dobato Ayuso, José Luis; Frank García, Ana; Valdivieso Amate, Fernando; Berciano, José ÁngelAutoridad Unican; Bullido, María Jesús; Combarros Pascual, OnofreAutoridad Unican
Fecha
2011-09-07
Derechos
Atribución 3.0 España
Publicado en
BMC Research Notes. 2011 Sep 7;4:327
Editorial
BioMed Central
Resumen/Abstract
BACKGROUND: Tau abnormal hyperphosphorylation and the formation of neurofibrillary tangles in AD brain is the result of upregulation of tau kinases and downregulation of tau phosphatases. METHODS: In a group of 729 Spanish late-onset Alzheimer's disease (AD) patients and 670 healthy controls, we examined variations into a set of candidate genes (PPP2CA, PPP2R2A, ANP32A, LCMT1, PPME1 and PIN1) in the tau protein phosphatase-2A (PP2A) pathway, to address hypotheses of genetic variation that might influence AD risk. RESULTS: There were no differences in the genotypic, allelic or haplotypic distributions between cases and controls in the overall analysis or after stratification by age, gender or APOE ε4 allele. CONCLUSION: Our negative findings in the Spanish population argue against the hypothesis that genetic variation in the tau protein phosphatase-2A (PP2A) pathway is causally related to AD risk.
Colecciones a las que pertenece
Atribución 3.0 EspañaExcepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España